Atrial Coronary Circulation in STEMI Patients With Newly Diagnosed Atrial Fibrillation
Key facts
- Who runs it
- Samara Regional Cardiology Dispensary
- Where
- Russia1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Not yet recruiting
- People taking part
- 1,200 people, planned
- Started
- 11 Nov 2026
- Expected to end
- Mar 2028
- Type of study
- Observational, 2 groups
- Treatments tested
- Atrial Coronary Artery Involvement
- Record updated
- 17 November 2026
Who can take part
- Age
- 18 years to 75 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 16 criteriaShow less
Who can take part
- Main cohort - STEMI patients with newly diagnosed atrial fibrillation: Age 18-75 years. ST-elevation myocardial infarction (STEMI) with symptom onset within 24 hours before enrollment; No history of atrial fibrillation before the index STEMI. First-ever episode of atrial fibrillation documented within the first 24 hours of hospitalization; Coronary angiography with or without percutaneous coronary intervention (PCI). Written informed consent
- Control cohort - STEMI patients without atrial fibrillation:; Age ≥18 years. STEMI with symptom onset within 24 hours before enrollment. No history of atrial fibrillation before the index STEMI. No first-ever episode of atrial fibrillation during hospitalization. Coronary angiography with or without PCI. Written informed consent
Who cannot take part
- Known history of AF prior to STEMI
- History of previous PCI or CABG
- Chronic Obstructive Pulmonary Disease stage ≥2
- History of Myocardial Infarction
- History of Valve Surgery
- Mitral or Tricuspid Valve insufficiency grade ≥ 2
- Malignancy in the active treatment phase or terminal cancer
- Time from onset of STEMI symptoms > 24 hours
- Hemodynamically significant Mitral Stenosis (<1.5 cm2)
- Permanent pacemaker
- Severe comorbidities (e.g., end-stage CKD, cirrhosis) with a life expectancy of less than 1 year
- Known thyrotoxicosis
- Non-invasive treatment strategy
- Patient's refusal to participate in the study
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 18 and 75 years old?
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This multicenter, prospective, observational, comparative cohort study will investigate the association between atrial coronary artery involvement and newly diagnosed atrial fibrillation (AF) in patients with ST-segment elevation myocardial infarction (STEMI).
Read full original descriptionShow less
Patients with acute STEMI undergoing coronary angiography will be assigned to two observational cohorts according to the development of AF during the first 24 hours of hospitalization: patients with a first-ever episode of AF and patients without AF, with the latter group matched by age and sex. Coronary angiograms will be assessed for thrombosis or stenosis of the arteries supplying the atria and for their relationship to the infarct-related artery.
The primary endpoint is the incidence of atrial coronary artery involvement in patients with newly diagnosed AF during acute STEMI. Secondary endpoints include all-cause and cardiovascular mortality, acute heart failure, thromboembolic complications, major bleeding, duration of hospitalization and intensive care stay, AF recurrence, cardioversion, and prescription of direct oral anticoagulants during hospitalization.
The study plans to enroll 400 participants, with 200 patients in each cohort. The study is non-interventional, and all diagnostic and therapeutic procedures will be performed according to standard clinical care. The follow-up will include the index hospitalization and a 30-day telephone assessment.
The 2 groups in the trial
- STEMI With Newly Diagnosed Atrial Fibrillation
Patients with STEMI who develop a first-ever episode of atrial fibrillation during the first 24 hours of hospitalization. Patients have no history of atrial fibrillation before STEMI and undergo coronary angiography with or without subsequent PCI.
Treatment: Atrial Coronary Artery Involvement
- STEMI Without Atrial Fibrillation
Patients with STEMI who do not develop atrial fibrillation during hospitalization. Patients have no history of atrial fibrillation before STEMI and undergo coronary angiography with or without subsequent PCI. The comparison cohort is matched by age and sex.
Treatment: Atrial Coronary Artery Involvement
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Atrial Coronary Circulation in STEMI Patients With Newly Diagnosed Atrial Fibrillation (ACC-AF-STEMI)
- Criteria questions
- Built from NCT07941947, who can take part
- Record updated
- 17 November 2026